Filomena Fezza
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Fatty acid amide hydrolase (FAAH) inhibitor design and preclinical studies: lessons learned from BIA 10-2474 and the challenges ahead.
Journal: Expert opinion on drug discovery
Published: August 19, 2026
Lipid Composition Drives Mutant Huntingtin Dimerization and Membrane Association: Insights from Computational Simulations.
Journal: Molecules (Basel, Switzerland)
Published: May 08, 2026
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs.
Journal: Cells
Published: February 27, 2025
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.
Journal: Frontiers in pharmacology
Published: May 01, 2024
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 31, 2023
Radiometric Assay of NAPE-PLD Activity.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 24, 2022
Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437.
Journal: ACS chemical biology
Published: April 28, 2022
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents.
Journal: ACS chemical neuroscience
Published: April 23, 2021
In Silico and In Vitro Analysis of Major Cannabis-Derived Compounds as Fatty Acid Amide Hydrolase Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: December 09, 2020
Bisphenol A Deranges the Endocannabinoid System of Primary Sertoli Cells with an Impact on Inhibin B Production.
Journal: International journal of molecular sciences
Published: October 24, 2020
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold?
Journal: Expert opinion on drug discovery
Published: April 16, 2020
Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme.
Journal: Scientific reports
Published: April 03, 2020
Last Updated: 09/26/2026